Bidil
NDC Package 52125-740-23

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Bidil is this medication contains 2 drugs (hydralazine and isosorbide dinitrate) and is used with other medications to treat heart failure. Marketed by Remedyrepack Inc., this product is identified by NDC 52125-740 and is authorized under FDA application NDA020727.

Identification & Billing

NDC Package Code
52125-740-23
Package Description
180 TABLET, FILM COATED in 1 BOTTLE
Product Code
52125-740
11-Digit Billing Format
52125074023

Clinical Specifications

Proprietary Name
Bidil
Dosage Form
-
Usage Information
This medication contains 2 drugs (hydralazine and isosorbide dinitrate) and is used with other medications to treat heart failure. Both drugs are known as vasodilators. They work by relaxing and widening blood vessels so blood can flow more easily to the heart.

Regulatory & Marketing

Labeler Name
Remedyrepack Inc.
FDA Application #
NDA020727
Marketing Category
NDA - A product marketed under an approved New Drug Application.
Start Marketing Date
10-08-2013
End Marketing Date
10-09-2013
Listing Expiration
10-09-2013
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 52125-740-23 identifies a specific commercial package of 180 tablet, film coated in 1 bottle of Bidil, labeled by Remedyrepack Inc.. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Remedyrepack Inc. on October 08, 2013. The current certification is valid through October 09, 2013.

What are the primary indications for this medication?

This medication contains 2 drugs (hydralazine and isosorbide dinitrate) and is used with other medications to treat heart failure. Both drugs are known as vasodilators. They work by relaxing and widening blood vessels so blood can flow more easily to the heart.

How is this Remedyrepack Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 52125074023. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
52125-740-23
11-Digit CMS (5-4-2)
52125-0740-23

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.